From December 1982 through September 1990, 27 patients with 32 tumors were treated with thermochemotherapy. Of the 32 tumors, 19 were locally recurrent tumors, 11 distant metastases, and 2 peritoneal disseminations. Employung two types of heating devices (8MHz capacitive RF, 430MHz microwave), hyperthermia was administered once or twice weekly, for 30-60 minutes per session, up to total sessions of 2-15 (mean = 6.4 ± 3.8). In some sessions, anticancer drugs were administered intraveneously or in-traarterially immediately before or simultaneously with hyperthermia. The number of thermochemitherapy sessions was 1-6 (mean = 3.0 ± 1.5). Of the 32 tumors treated, 2 (6%) showed CR, 13 (41 %) PR, 11 (34%) NC, and 6 (19%) PD. The better the tumor response was, the higher local control rate was achieved. The survival rate of patients who achieved CR or PR was higher than that of patients who showed NC or PD. Tumor volume, depth of tumor, average tumor temperature, minimum tumor temperature, the numer of effective heat sessions and varieties of anticancer drugs used were shown to affect the tumor response by multivariate analysis. On the other hand, radiotherapy or chemotherapy history did not affect the tumor response. As almost all the tumors treated were considered to be refractory to radiotherapy or chemotherapy, the tumor responses obtained with thermochemotherapy seemed very encouraging. The expanded trials are warranted to reveal the effectiveness of thermochemotherapy.
View full abstract